Sustainability  /  Ireland

Caring for Our Patients, Caring for Our Planet

Welcome to the EXOGEN Recycling Programme for the Republic of Ireland. The programme provides recycling of EXOGEN devices that have reached the end of their usage.

Instructions for patients in Ireland:

If you received your device from a hospital or have been encouraged to return your device to your care provider:

  • Return your device to your treatment facility. Your treatment facility will be able to recycle the device following the steps outlined below.

If you purchased the device yourself or are unable to return your device to your treatment facility:

  • Your EXOGEN device and the charger can be deposited at your nearest Civic Amenity Site. Learn more here (you will leave Bioventus’ page).
  • Or, place the EXOGEN device and charger into a household electronic waste bin, and place the user manual in paper recycling.
  • Note: The gel bottle and carrier tote cannot be recycled. Dispose of these items separately.

Instructions for providers in Ireland:

  • Encourage patients to bring their device with them to every follow-up appointment.
  • When a patient has completed treatment, consult your hospital’s disposal pathway for used electronic goods; the EXOGEN device and charger can be moved through this pathway for recycling. The device user manual can be placed in paper recycling.
    • Used electronic goods will be collected by the European Recycling Platform (ERP) or by WEEE Ireland, the Irish Compliance Scheme for Electrical and Battery Recycling, depending on your location.
    • Request a collection from ERP here (you will leave Bioventus’ page).
    • Request a collection from WEEE Ireland here (you will leave Bioventus’ page).
  • Note: The gel bottle and carrier tote cannot be recycled. Dispose of these items separately.

Summary of Indications for Use
EXOGEN is indicated for the non-invasive treatment of osseous defects (excluding vertebra and skull) that includes the treatment of delayed unions, nonunions,* stress fractures and joint fusion. EXOGEN is also indicated for the acceleration of fresh fracture heal time, repair following osteotomy, repair in bone transport procedures and repair in distraction osteogenesis procedures.

There are no known contraindications for the EXOGEN device. Safety and effectiveness have not been established for individuals lacking skeletal maturity, pregnant or nursing women, patients with cardiac pacemakers, on fractures due to bone cancer, or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel.

Full prescribing information can be found in product labeling, at EXOGEN.com, or by calling Bioventus Customer Service.

*A nonunion is considered to be established when the fracture site shows no visibly progressive signs of healing.